Search details
1.
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Haemophilia
; 28(4): 548-556, 2022 Jul.
Article
in English
| MEDLINE | ID: mdl-35475308
2.
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Haemophilia
; 27(6): 911-920, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34614267
3.
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Haemophilia
; 27(6): 921-931, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34636112
4.
Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A.
Hum Gene Ther
; 33(7-8): 432-441, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35156839
5.
Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1.
Pediatr Infect Dis J
; 37(5): 459-465, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29023357
Results
1 -
5
de 5
1
Next >
>>